Peripheral neuropathy decisions — 2025

The Board granted a 40 percent rating for right upper extremity ulnar neuropathy and denied an increased rating for left upper extremity ulnar neuropathy.

The Board denied the veteran's claims for service connection for various conditions, finding no new and relevant evidence to support a change in previous denials.

The Board denied service connection for high cholesterol and remanded the claims for prostate cancer, arthritis, diabetes type II, end stage renal disease on dialysis, nerve pain (including diabetic neuropathy), and kidney cancer for further development.

The Board denied the Veteran's claim for special monthly compensation based on loss of use of both hands due to his bilateral upper extremity polyneuropathy not meeting the criteria for such compensation.

The Board remands the claim for a nerve disability affecting the left upper extremity to obtain an addendum opinion addressing its etiology.

The Board granted service connection for urinary dysfunction, right upper extremity peripheral neuropathy, and left upper extremity peripheral neuropathy as secondary to the Veteran's service-connected diabetes mellitus type II with diabetic retinopathy.

The Board granted a 70 percent rating for PTSD prior to February 2, 2021, and a 100 percent rating from that date forward, while dismissing the appeals for increased ratings for sciatica neuropathy.

The Board remands the claims for an earlier effective date for TDIU and SMC at the housebound rate due to errors by the RO in satisfying a regulatory duty under 4.16(b).

The Board remands the claims for service connection for peripheral vascular disease, right bundle branch block, and mononeuropathy of both lower extremities due to a need for further medical opinions.

The Board denied the veteran's claims for earlier effective dates, increased ratings, and service connection due to a lack of evidence supporting these claims.

The Board denied increased ratings for the Veteran's peripheral neuropathies of the radial and sciatic nerves in both upper and lower extremities, finding that the current evaluations accurately reflect the severity of his conditions.

The Board remands the claim for a new medical opinion regarding the relationship between upper extremity peripheral neuropathy and exposure to contaminated water at Camp Lejeune.

The Board remands the claim for an initial rating in excess of 20 percent for left ulnar neuropathy to obtain additional medical records.

The Board remands the veteran's claims for increased ratings and TDIU due to outstanding medical records and the need for new VA examinations.

The Board remands the claims for an increased rating in excess of 10 percent for multinodular goiter with intermittent hyperthyroidism and syncopal episodes associated with paroxysmal atrial fibrillation, and in excess of 20 percent for femoral neuropathy, left leg, due to a lack of substantial compliance with the previous remand instructions.

The Veteran's appeal for an earlier effective date of August 23, 2010 is granted for entitlement to special monthly compensation due to housebound status. The other appeals are dismissed as moot.

The Board remands the claims for service connection for left knee strain, lower back condition, and nerve paralysis of the left lower extremity to obtain a direct medical opinion.

The Board remands the claims for service connection for peripheral neuropathy of both lower extremities due to inadequate medical evidence and an unclear opinion from the VA examiner.

The Board denied service connection for sinusitis and remanded claims related to earlier effective dates, peripheral neuropathy, and ED.

The Board granted service connection for peripheral neuropathy in both the right and left lower extremities, finding that these conditions are presumptively linked to herbicide exposure during the Veteran's service in Vietnam.